Home / Doxorubicin / Germany
DE ATC L01DB01 · updated 2 Nov 2026
Doxorubicin shortage in Germany
Is there a Doxorubicin shortage in Germany?
Yes. As of 2 Nov 2026, 3 Doxorubicin products are reported short in Germany, the first since 16 Aug 2024. The company estimate for the return is 31 Dec 2026 (latest 19 Jan 2027). Main reason: manufacturing problem.
Also short in Canada, Italy, Ireland, Austria, Belgium, Czechia, Sweden. All countries.
Affected products in Germany
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| DE | DOXO-cell 50 mg Injektionslösung | STADAPHARM GmbH | 16 Aug 2024 | 19 Jan 2027 | Manufacturing problem Probleme in der Herstellung |
| DE | DOXO-cell 150 mg Injektionslösung | STADAPHARM GmbH | 16 Sep 2024 | 19 Jan 2027 | Manufacturing problem Probleme in der Herstellung |
| DE | Doxorubicinhydrochlorid Bendalis 2 mg/ml | BENDALIS GmbH | 15 Nov 2024 | 31 Dec 2026 | Manufacturing problem Probleme in der Herstellung |
Source
BfArM (Federal Institute for Drugs and Medical Devices), via PharmNet.Bund. Official list. Supply-relevant medicines reported under a voluntary self-commitment; mostly hospital-relevant products.